Market Research

Nifedipine Market Size Forecast to Reach $1.37 Billion by 2025

Product Type- Segment Analysis

The Nifedipine Controlled Release Tablet segment held the largest share in the Nifedipine Market in 2019 and is estimated to grow at a CAGR of 4.85% during the forecast period 2020-2025 owing to its use to treat angina and high blood pressure. Both the nifedipine immediate-release capsules and extended-release tablets are available as generic drugs. It helps to prevent strokes, heart attacks, and kidney problems. Tachycardia occur as a reaction when patients feel dizzy or faint after taking the first few doses of nifedipine controlled-release tablets. These problems are much less frequent within the sustained-release preparations of nifedipine. Nifedipine controlled-release tablet is used to treat severely high blood pressure in pregnancy and is sold under the brand name Adalat which is used to manage Raynaud’s phenomenon and premature labor. Nifedipine Controlled Release Tablet is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

Application – Segment Analysis

The Premature Labor held the largest share in the Nifedipine Market in 2019 owing to its usage in preterm labor that allows more time for steroids to improve the baby’s lung function and to treat severely high blood pressure in pregnancy. It is used as a tocolytic which is an agent that delays premature labor and benefits over placebo or no treatment for prolongation of pregnancy. Raynaud’s Syndrome is also treated with nifedipine as it is a calcium channel blocker which is the most potent vasodilator. Nifedipine is a calcium channel blocker that affects the movement of calcium within the cells of the guts and blood vessels. As a result, calcium channel blockers release blood vessels and increase the supply of blood and oxygen to the heart, reducing the chance of heart failure. Premature Labor is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025 owing to its effective use to treat severe hypertension in preterm labor.

Report Price: $ 4500 (Single User License)

Geography – Segment Analysis

North America dominates the nifedipine market with a share of more than 37.7%, followed by the Asia Pacific owing to the increasing number of higher blood pressure patients. Nifedipine is used to treat high blood pressure. It lowers the blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. Increasing incidence of chronic diseases like heart failure and arrhythmias is also increasing the growth of the nifedipine market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increasing incidence of lightheadedness and to control angina which is a kind of chest pain.

 

Drivers – Nifedipine Market 

  • Increasing hypertension and increasing incidence of chronic diseases

Increasing hypertension and increasing the incidence of chronic disease is increasing the growth of the nifedipine market. Nifedipine is a calcium channel blocking agent that is used to treat high blood pressure. It helps to prevent future heart disease, heart attacks, and strokes to the person who is having high blood pressure. Nifedipine lowers the blood pressure and makes it easier for the heart to pump blood around the body. Hypertension is a significant contributor to cardiovascular events, cardiac death, and kidney disease. Nifedipine is a dihydropyridine calcium channel blocker and short-acting formulation of it is associated with a reflex sympathetic nervous system worsening myocardial ischemia and cerebrovascular ischemia; therefore only longer-acting formulations of nifedipine should be taken for reducing hypertension. Thus, increasing the Nifedipine market during the forecast period 2020-2025.

  • Increasing usage of nifedipine in preterm labor to improve the baby’s lung function and to treat severely high blood pressure in pregnancy

Increasing usage of nifedipine in preterm labor to improve the baby’s lung function and to treat severely high blood pressure in pregnancy is increasing the growth of the nifedipine market owing to its effective use to treat severe hypertension in pregnancy and preterm labor. Nifedipine is a calcium chain blocker that is used to reduce blood pressure and to relax uterine contractions and postpone a preterm birth. The uterus is made up of thousands of muscle cells. When calcium flows to the cell, the muscle relaxes and calcium chain blocker prevents calcium to move into the muscle cells of the uterus making it less able to contract. Nifedipine can reduce the number of frequency of contractions but its effect and how long it lasts that varies from one woman to another. Thus, increasing the nifedipine market during the forecast period 2020-2025.

Challenges – Nifedipine Market  

  • Stringent government regulations and congestive heart failure 

Some of the factors which can impede the growth of the Nifedipine markets are stringent government regulations and side effects like hypotension and congestive heart failure.

Nifedipine Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the nifedipine market. In 2019, Nifedipine Market share is consolidated by the top ten players present in the market. Nifedipine, the top 10 companies are  Abbott Laboratory, AstraZeneca Plc, Boehringer Ingelheim Gmbh, F. Hoffmann-La Roche Ag, GlaxoSmithKline Plc, Merck Co, Inc, Novartis Ag, Pifizer Inc, Teva Pharmaceutical Industry Ltd, and Vectura Group Plc among others

Acquisitions/Product Launches

  • In June 2017, Abbott Laboratory acquired St. Jude Medical.
  • In January 2019, Glaxosmithkline Plc acquired Tesaro.

Key Takeaways

  • North America dominated the Nifedipine Market in 2019 owing to the increasing number of higher blood pressure patient and increasing number of heart disease. The Nifedipine Market scope for different regions will be provided in the final report.
  • Increasing hypertension and rising number of cirrhosis patients is likely to aid in the market growth of Nifedipine.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Nifedipine Market report.
  • Stringent government regulations and congestive heart failure is poised to create hurdles for the Nifedipine Market.

Related Report :

Biomedical Sensor Market

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Keywords:    Nifedipine Market, Nifedipine Market size, Nifedipine industry, Nifedipine Market share, Nifedipine top 10 companies, Nifedipine Market report, Nifedipine industry outlook